Is CTI BioPharma Corp (CTIC) Stock at the Top of the Biotechnology Industry?

Friday, May 19, 2023 01:13 PM | InvestorsObserver Analysts

Mentioned in this article

Is CTI BioPharma Corp (CTIC) Stock at the Top of the Biotechnology Industry?

A rating of 82 puts CTI BioPharma Corp (CTIC) near the top of the Biotechnology industry according to InvestorsObserver. CTI BioPharma Corp's score of 82 means it scores higher than 82% of stocks in the industry. CTI BioPharma Corp also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 23 out of the 148 industries.

CTIC has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With CTI BioPharma Corp Stock Today?

CTI BioPharma Corp (CTIC) stock has risen 0.17% while the S&P 500 is down -0.14% as of 12:56 PM on Friday, May 19. CTIC has gained $0.02 from the previous closing price of $8.92 on volume of 2,091,299 shares. Over the past year the S&P 500 is higher by 7.47% while CTIC has gained 83.57%. CTIC lost -$0.58 per share the over the last 12 months. Click Here to get the full Stock Report for CTI BioPharma Corp stock.